As gene therapy emerges as a potential new treatment approach for hemophilia, ISTH is proud to introduce Gene Therapy in Hemophilia: An ISTH Education Initiative. This new comprehensive resource for healthcare professionals and scientists offers critical education to the global community on the evolving science and clinical developments in gene therapy in hemophilia.
Improve your understanding of the fundamentals of gene therapy, and stay abreast of the latest clinical advances with gene therapy in hemophilia by learning from leading international experts on this dynamic educational platform. Learn about tomorrow, today, by visiting our booth located in the main foyer/registration area or attend the announcement session on Sunday, July 7 from 12:15-13:00 in Product Theater D.
Learn more about the Gene Therapy in Hemophilia initiative here.